178 related articles for article (PubMed ID: 36139501)
1. MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer.
Manai M; ELBini-Dhouib I; Finetti P; Bichiou H; Reduzzi C; Aissaoui D; Ben-Hamida N; Agavnian E; Srairi-Abid N; Lopez M; Amri F; Guizani-Tabbane L; Rahal K; Mrad K; Manai M; Birnbaum D; Mamessier E; Cristofanilli M; Boussen H; Kharrat M; Doghri R; Bertucci F
Cells; 2022 Sep; 11(18):. PubMed ID: 36139501
[TBL] [Abstract][Full Text] [Related]
2. MARCKS protein overexpression in inflammatory breast cancer.
Manai M; Thomassin-Piana J; Gamoudi A; Finetti P; Lopez M; Eghozzi R; Ayadi S; Lamine OB; Manai M; Rahal K; Charafe-Jauffret E; Jacquemier J; Viens P; Birnbaum D; Boussen H; Chaffanet M; Bertucci F
Oncotarget; 2017 Jan; 8(4):6246-6257. PubMed ID: 28009981
[TBL] [Abstract][Full Text] [Related]
3. The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells.
Salem I; Alsalahi M; Chervoneva I; Aburto LD; Addya S; Ott GR; Ruggeri BA; Cristofanilli M; Fernandez SV
Breast Cancer Res; 2016 Mar; 18(1):37. PubMed ID: 27009091
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival.
Bertucci F; Ueno NT; Finetti P; Vermeulen P; Lucci A; Robertson FM; Marsan M; Iwamoto T; Krishnamurthy S; Masuda H; Van Dam P; Woodward WA; Cristofanilli M; Reuben JM; Dirix L; Viens P; Symmans WF; Birnbaum D; Van Laere SJ
Ann Oncol; 2014 Feb; 25(2):358-65. PubMed ID: 24299959
[TBL] [Abstract][Full Text] [Related]
5. A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis.
Chen CH; Thai P; Yoneda K; Adler KB; Yang PC; Wu R
Oncogene; 2014 Jul; 33(28):3696-706. PubMed ID: 23955080
[TBL] [Abstract][Full Text] [Related]
6. MARCKS protein overexpression is associated with poor prognosis in male breast cancer.
Manai M; Abdeljaoued S; Goucha A; Adouni O; Bettaieb I; Bouzaien H; Rahal K; Birnbaum D; Bertucci F; Gamoudi A
Cancer Biomark; 2019; 26(4):513-522. PubMed ID: 31771045
[TBL] [Abstract][Full Text] [Related]
7. Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications.
Chen CH; Statt S; Chiu CL; Thai P; Arif M; Adler KB; Wu R
Am J Respir Crit Care Med; 2014 Nov; 190(10):1127-38. PubMed ID: 25318062
[TBL] [Abstract][Full Text] [Related]
8. Tackling MARCKS-PIP3 circuit attenuates fibroblast activation and fibrosis progression.
Yang DC; Li JM; Xu J; Oldham J; Phan SH; Last JA; Wu R; Chen CH
FASEB J; 2019 Dec; 33(12):14354-14369. PubMed ID: 31661644
[TBL] [Abstract][Full Text] [Related]
9. Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.
Ogony J; Choi HJ; Lui A; Cristofanilli M; Lewis-Wambi J
Breast Cancer Res; 2016 Feb; 18(1):25. PubMed ID: 26897526
[TBL] [Abstract][Full Text] [Related]
10. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity.
Rypens C; Marsan M; Van Berckelaer C; Billiet C; Melis K; Lopez SP; van Dam P; Devi GR; Finetti P; Ueno NT; Bertucci F; Dirix P; Neven P; Vermeulen P; Dirix L; Van Laere SJ
Breast Cancer Res Treat; 2020 Apr; 180(2):385-395. PubMed ID: 32043194
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Upregulation of Myristoylated Alanine-Rich C-Kinase Substrate in Gastric Cancer.
Quan R; Ning Z; Wang Y; Yu W; Zhu H
Med Sci Monit; 2019 Jan; 25():279-287. PubMed ID: 30623893
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target.
Chen CH; Fong LWR; Yu E; Wu R; Trott JF; Weiss RH
Oncogene; 2017 Jun; 36(25):3588-3598. PubMed ID: 28166200
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines.
Hillyer RL; Sirinvasin P; Joglekar M; Sikes RA; van Golen KL; Nohe A
Clin Exp Metastasis; 2012 Dec; 29(8):971-9. PubMed ID: 22610818
[TBL] [Abstract][Full Text] [Related]
15. Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivity.
Rohrbach TD; Jarboe JS; Anderson JC; Trummell HQ; Hicks PH; Weaver AN; Yang ES; Oster RA; Deshane JS; Steele C; Siegal GP; Bonner JA; Willey CD
Int J Oncol; 2015 Mar; 46(3):1079-88. PubMed ID: 25524703
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation.
Lacerda L; Reddy JP; Liu D; Larson R; Li L; Masuda H; Brewer T; Debeb BG; Xu W; Hortobágyi GN; Buchholz TA; Ueno NT; Woodward WA
Stem Cells Transl Med; 2014 Jul; 3(7):849-56. PubMed ID: 24833589
[TBL] [Abstract][Full Text] [Related]
17. Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value.
Doghri R; Manai M; Finetti P; Driss M; Agavnian E; Lopez M; Elghardallou M; Charafe-Jauffret E; Manai M; Chaffanet M; Birnbaum D; Mrad K; Bertucci F
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295532
[TBL] [Abstract][Full Text] [Related]
18. EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab.
Gori S; Sidoni A; Colozza M; Ferri I; Mameli MG; Fenocchio D; Stocchi L; Foglietta J; Ludovini V; Minenza E; De Angelis V; Crinò L
Ann Oncol; 2009 Apr; 20(4):648-54. PubMed ID: 19188134
[TBL] [Abstract][Full Text] [Related]
19. miR-181c promotes proliferation via suppressing PTEN expression in inflammatory breast cancer.
Zhang WL; Zhang JH
Int J Oncol; 2015 May; 46(5):2011-20. PubMed ID: 25695913
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast Migration Is Regulated by Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Protein.
Ott LE; Sung EJ; Melvin AT; Sheats MK; Haugh JM; Adler KB; Jones SL
PLoS One; 2013; 8(6):e66512. PubMed ID: 23840497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]